NCT03716323

Brief Summary

Immediate implant placement has the disadvantage of difficulty in obtaining primary stability, lack of adequate soft tissue coverage and also the control of the implant position is difficult in addition to the cost of the graft. Autogenous bone graft is considered to be the golden standard for grafting as it has osteoconductive , osteoinductive and osteogenic functions , however it has the problems of donor site morbidity , the need for two surgeries as well as post operative swelling and discomfort of the patient , so alternative bone grafts as allografts and xenografts, has been introduced.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2018

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2018

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 23, 2018

Completed
9 days until next milestone

Study Start

First participant enrolled

November 1, 2018

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

October 23, 2018

Status Verified

October 1, 2018

Enrollment Period

11 months

First QC Date

October 21, 2018

Last Update Submit

October 21, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Marginal Bone Loss

    The amount of marginal bone loss will be measured using cone beam computed tomography

    6 months

Study Arms (1)

immediate premolar implant with xenograft and allograft

EXPERIMENTAL

Immediate Implant Placement in Maxillary Premolar zone with grafting the jumping gap using xenograft and allograft

Device: immediate premolar implant with xenograft and allograft

Interventions

* A peritome will be used for atraumatic extraction of remaining roots. * The extraction socket will be evaluated for absence of any fenestration or granulation tissues. * Copious normal saline irrigation and curettage will be performed. * In the study group: Immediate implant insertion following standard manufacturer's recommended surgical protocol followed by grafting the jumping gap with cortico-cancellous allograft (MinerOss®, BioHorizons, USA) * In the control group: Immediate implant insertion following standard manufacturer's recommended surgical protocol followed by grafting the jumping gap with anorganic bovine bone mineral xenograft (Bio-Oss®, Geistlich, USA)

immediate premolar implant with xenograft and allograft

Eligibility Criteria

Age25 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients with badly broken teeth in upper premolar zone indicated for extraction, presence of at least 3 mm of bone beyond the root apex to guarantee implant primary stability, implant placement within the alveoli confines.
  • Both sexes.
  • No intraoral soft and hard tissue pathology.
  • No systemic condition that contraindicate implant placement.

You may not qualify if:

  • Presence of fenestrations or dehiscence of the residual bony walls after extraction.
  • Heavy smokers more than 20 cigarettes per day.
  • Patients with systemic disease that may affect normal healing.
  • Psychiatric problems
  • Disorders to implant are related to history of radiation therapy to the head and neck neoplasia, or bone augmentation to implant site.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Transplantation, HeterologousTransplantation, Homologous

Intervention Hierarchy (Ancestors)

TransplantationSurgical Procedures, Operative

Central Study Contacts

Ahmed M Abdallah, BDS

CONTACT

Mohamed Mounir, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

October 21, 2018

First Posted

October 23, 2018

Study Start

November 1, 2018

Primary Completion

October 1, 2019

Study Completion

November 1, 2019

Last Updated

October 23, 2018

Record last verified: 2018-10